The Latest Biology News And Medical NewsBiology News 2Health News 2Biology News 3Health News 3
HOME >> MEDICINE >> NEWS
The Mount Sinai Medical Center recognized for excellence in bariatric surgery

New York, NY -- The Mount Sinai Medical Center has been named a Bariatric Surgery Center of Excellence by the American Society for Bariatric Surgery (ASBS). This new designation recognizes the safety, efficiency and overall positive surgical results of the bariatric surgical team at Mount Sinai. The hospital has satisfactorily met the high standards set forth by the ASBS to be acknowledged for its excellence in bariatric surgery.

Obesity is a serious epidemic in America. Over two thirds of Americans are overweight, a frightening number that continues to rise each year. Faced with this issue, the leadership of the American Society for Bariatric Surgery identified the need to recognize surgical programs, like Mount Sinai's Program for Surgical Weight Loss, that demonstrate a track record of favorable outcomes in bariatric surgery.

The Chief of Bariatric Surgery at The Mount Sinai Medical Center, Dr. Daniel M. Herron, MD, FACS couldn't be prouder of the new designation for the hospital and the hard work of his entire surgical team. "The Mount Sinai Medical Center staff has been providing an extraordinary level of care to weight loss surgery patients since 1999. It's very satisfying to see this officially recognized at the national level by the ASBS," said Herron.

Dr. Herron has been performing laparoscopic bariatric surgery since joining the Mount Sinai faculty in 1999. Since that time he has performed over 700 laparoscopic bariatric procedures. Dr. Herron also serves as Director of the Laparoscopic Surgery Fellowship training program at Mount Sinai School of Medicine, where he is an Associate Professor of Surgery.

The ASBS Centers of Excellence Program was created to recognize bariatric surgery centers that perform well. To earn a Center of Excellence designation, Mount Sinai underwent a series of site inspections during which all aspects of the program's surgical processes were closely examined and data on health outc
'"/>

Contact: Mount Sinai Press Office
newsmedia@mssm.edu
212-241-9200
The Mount Sinai Hospital / Mount Sinai School of Medicine
26-Jul-2006


Page: 1 2

Related medicine news :

1. New breakthrough treatment for spinal cancer patients at Mount Sinai
2. Mount Sinai and EXACT Sciences announce study results on study stool DNA testing for colon cancer
3. Wiley to assume publication of Mount Sinai Journal of Medicine
4. Mount Sinai researcher finds drinking water safe to drink
5. Mount Sinai Global Health Center receives $1M grant
6. Mount Sinai School of Medicine receives prestigious AAMC Grant for Chronic Illness Care education
7. Mount Sinai and YAI/NIPD Network join forces to further quality of care for people with autism
8. Mount Sinai launches combination therapy trial to treat Relapsing-Remitting Multiple Sclerosis
9. CNIC commits 5 million Euros to the Mount Sinai School of Medicine
10. Mount Sinai expands cutting-edge molecular testing
11. Mountain bikers are cautioned to ride with care - major injuries do happen

Post Your Comments:
(Date:11/25/2009)...zlesmile,llc www.dazzlesmile.com andOptimalHealthS...67-pagefederallawsuitagainstEpicAdvertisingAKAAzoo...esLimited,andAtLastFulfillment.The13-countComplain...ictofUtah,allegesmassivenationalconsumerfraud,coun...oducts,violationsoftheRacketeeringInfluencedandCor...
(Date:11/25/2009)...roveOverallOutcomesforLungCancer ,, WASHINGTO...rAlliance-California(LCA-CA)issuedits2ndAnnual Rep...ntofprogressbeingmadeagainstthislethaldiseaseinthe...ance(LCA),theonlynationalorganizationdedicatedexcl...ithoratriskforlungcancer. ,, (Photo: http://www...
(Date:11/25/2009)...matology (ASH) is pleased to recognize the followi...bstracts in the categories of undergraduate studen...ysician, and post-doctoral,fellow. Merit Award wi...g,travel reimbursement. , The 2009 Merit Award ...imberly Fan , Donor Dendritic Cells Home to Lymph...
(Date:11/25/2009)... , An innovative treatment for HIV patients dev...ers has passed its first clinical trial with flyin...stomized for each individual patient, and was deve...e of the MUHC in collaboration with Dr. R. Skaly f...ade for the individual patient an "haute couture"...
(Date:11/25/2009)...atients with liver lesions, researchers find , ...ding the drug cetuximab to neoadjuvant chemotherap...ul surgery in colorectal cancer patients with inop...ests. , , Tumors spread to other parts of the ... cancer. Most commonly, the cancer spreads to the ...
Breaking Medicine News(10 mins):Health News:dazzlesmile Sues Epic Advertising and Jesse Willms 2Health News:Lung Cancer Alliance-California Releases 2nd Annual State-Specific Report Card On Lung Cancer 2Health News:ASH announces 2009 Merit Award winners 2Health News:Tailor-made HIV/AIDS treatment closer to reality 2Health News:Cetuximab Helps Treat Colorectal Cancer 2
(Date:11/25/2009)....25/PRNewswire-FirstCall/--Abaxis,Inc.(Nasdaq: ABA...arebloodanalysissystems,announcedtodaythatClintSev...atthe21stAnnualPiperJaffrayHealthCareConferenceonW...illbeheldattheNewYorkPalaceHotelinNewYorkCity. ,...andmarketsportablebloodanalysissystemsforuseinanyv...
(Date:11/25/2009)...wswire-FirstCall/--NuVasive,Inc.(Nasdaq: NUVA ),am...inimallydisruptivesurgicaltreatmentsforthespine,an...November30,2009,at5:30p.m.ET/2:30p.m.PT.Theconfere...mentfortheCompany,sproductsandwillincludecommentsf...ion.Thedial-innumbersare1-877-407-4018fordomesticc...
(Date:11/25/2009)...swire/--Reportlinker.comannouncesthatanewmarketres...nasalDrugDelivery-USMarketTrends&Analysis htt...Delivery---US-Market-Trends--Analysis.html ,, ...ansionoftherapeuticapplicationsfromthedeliveryofco...emictherapeuticdrugs.Thefutureofthetechnologyhinge...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5Sentry Data Systems Announces Claims Guardian 28TM 29 50150 1Sentry Data Systems Announces Claims Guardian 28TM 29 50150 2Sentry Data Systems Announces Claims Guardian 28TM 29 50150 3Clavis Pharma Raises NOK 129 Million 28USD 20 Million 29 in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug 12798 1Clavis Pharma Raises NOK 129 Million 28USD 20 Million 29 in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug 12798 2Clavis Pharma Raises NOK 129 Million 28USD 20 Million 29 in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug 12798 3Clavis Pharma Raises NOK 129 Million 28USD 20 Million 29 in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug 12798 4Clavis Pharma Raises NOK 129 Million 28USD 20 Million 29 in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug 12798 5Brown Takes Over Reins as Chair of AOSSM Medical Publishing Board of Trustees 50148 1Brown Takes Over Reins as Chair of AOSSM Medical Publishing Board of Trustees 50148 2Brown Takes Over Reins as Chair of AOSSM Medical Publishing Board of Trustees 50148 3
Other News:
...ng stents are effective in keeping open diseased h...s who need to have non-cardiac surgery a short tim...ntation at the Society for Cardiovascular Angiogra...at Jefferson Medical College indicates that for th...
...e treatment of heart attack, the 90-minute goal fo... coronary artery to restore normal blood flow is s..., accreditation standards, and pay-for-performance...itical" Two experts will debate that question at t...
...ent with double-dose anticlotting medication just ...ts the combined risk of heart attack and cardiac d... 30th Annual Scientific Sessions of the Society fo...AI), May 912, 2007, in Orlando, FL. ... Researcher...
WASHINGTON, May 11 Adults with high blood pressure and additional risk factors for heart disease may benefit more from taking one tablet rather than two, if their current treatment combines the lipid
health news:Bare-metal stents are better for some heart patients 2health news:Debate focuses on door-to-balloon time in heart attack treatment 2health news:High-dose anticlotting drug cuts heart attack, death risk in half 2health news:One pill may be better than two for treating patients with high blood pressure 2health news:One pill may be better than two for treating patients with high blood pressure 3
...seeking people with arthritis to help them better ...fects their symptoms. The study will investigate t...processes of those with arthritis.......Research p...mmon in people with arthritis, and arthritis patie...
...form many separations of molecules before they beg...ive compound or sub-compound into a drug.......Des...st chemically benign separation processes has not ...inia Tech researchers with support from Procter & ...
...-income single mothers have a very high prevalence...n Peden, ARNP, BC, DSN at the University of Kentuc... women with children between the ages of 2 and 6 w...ipants' survey results showed that more than 75% s...
...ected to grow faster than the population in the ne...creased demand in 89 of the state's 102 counties, ...ois State Water Survey.... ..."These studies proje...her states in the Midwest, information that is cri...
health news:Countywide forecasts of water use available for Illinois, Midwest 2health news:Countywide forecasts of water use available for Illinois, Midwest 3